Skip to main content

Tiziana Life Sciences Ltd

TLSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723069

No open-market purchases or sales by Tiziana Life Sciences Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q3 2026, worth $4.43M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 20, 2026
$74.8M
Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +4 vs. previous quarter
35
13F valueReported value at the end of Q3 2026
$4.43M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2024
–
No comparable prior period
Net income, FY2024
-$11.9M
No comparable prior period
Free cash flow, FY2024
-$1.54M
No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
2.92M
Shares sold short
Change
+131.4K
+4.7% vs. previous
Days to cover
6.98
At average daily volume

Superinvestors holding TLSA, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding TLSA at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Tiziana Life Sciences Ltd insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 7, 2026 (view filing)4:16 PM ETJul 2117 daysCerrone Gabriele MDirector, 10% OwnerPPurchase+42.4K$0.99+$41.9K+0.1%44.8M afterAmended
Aug 7, 2026 (view filing)4:15 PM ETJun 1256 daysCerrone Gabriele MDirector, 10% OwnerPPurchase+15.0K$1.11+$16.6K0.0%44.8M afterAmended
Aug 6, 2026 (view filing)9:30 AM ETAug 4-52 daysElrifi IvorChief Executive OfficerPPurchase+321.4K$0.9922+$318.9K+7.2%4.79M after2 lots
Aug 5, 2026 (view filing)4:30 PM ETAug 32 daysElrifi IvorChief Executive OfficerPPurchase+667.0K$1.00+$667.0K+17.5%4.47M after

Top 10 13F holders, Q3 2026

See all 35 holders

The largest institutional positions in Tiziana Life Sciences Ltd at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding TLSA in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Marshall Wace, LLP1,184,845$1.32M0.00%+1,184,845New
Citadel Advisors LLC615,965$683.7K0.00%+535,743+667.8%Added
Renaissance Technologies LLC500,133$555.1K0.00%+487,033+3,717.8%Added
Mid-American Wealth Advisory Group, Inc.448,667$498.0K0.17%+125,427+38.8%Added
Dauntless Investment Group, LLC301,001$334.1K0.61%−860,999−74.1%Reduced
Goldman Sachs Group Inc152,611$169.4K0.00%+33,373+28.0%Added
Zhang Financial LLC140,350$155.8K0.00%+14,400+11.4%Added
Jane Street Group, LLC120,816$134.1K0.00%+107,022+775.9%Added
Colony Group, LLC79,365$88.1K0.00%00.0%Unchanged
HSBC Holdings PLC62,437$67.4K0.00%00.0%Unchanged

Holders of 5% or more of TLSA

See all 1 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Tiziana Life Sciences Ltd.

Largest holders of TLSA from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Fonda Laura Natalia Monica13G5.70%6.81M shares–May 4, 20222 filingsOct 28, 2025SEC